Multicenter Study Into Individualized Scanning for Coronary Artery Disease
NCT ID: NCT04837846
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2021-03-29
2024-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To evaluate the radiation dose and contrast media dose of this individualized approach for CCTA in an American, European and Chinese patient population.
To evaluate the injection parameters required for an average American, European and Chinese patient population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease
NCT04272060
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
NCT01584622
Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 3
NCT04707859
Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI
NCT05880355
Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
NCT02284191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prospective CCTA Arm
Differing Tube Voltage Administration
Subjects will undergo CCTA utilizing a scan and contrast media injection protocol that will be tailored to individual body habitus.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Differing Tube Voltage Administration
Subjects will undergo CCTA utilizing a scan and contrast media injection protocol that will be tailored to individual body habitus.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Referred for a clinically indicated CCTA scan.
2. Patient aged older than 18.
3. Subject must provide written informed consent prior to any study-related procedures being performed.
4. Subject must be willing to comply with all clinical study procedures.
5. Atypical or typical complaints of angina.
6. No previous cardiovascular history.
7. Possibility of 'flash' mode scan; patient heart rate below 70 beats per minute and regular rhythm.
Exclusion Criteria
1. Contraindications for CT coronary angiography, including:
1. Inability to perform a breath hold for at least the expected scan time
2. Unstable angina
3. Hemodynamic instability
4. Known history of CAD
5. Pregnancy
6. Renal insufficiency (defined as Creatinine \<1.5 mg/dL or GFR\<30 mL/min)
7. Iodine allergy
2. Insufficient cannula venous access (preferred 18G, minimal 20G cannula)
3. Subject has an acute psychiatric disorder.
4. Subject is unwilling to comply with the requirements of the protocol.
5. Subject has previously entered this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph U. Schoepf, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00093255
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.